Renal Cell Carcinoma Diagnostics

15-Gene Signature Predicts RFS, DFS in Patients With ccRCC
To help risk stratify clear cell renal cell carcinoma (ccRCC), Rohit Mehra, MD, and colleagues developed a gene expression signature to predict recurrence-free survival (RFS) and disease-free survival (DFS) in this patient population. A discovery cohort was developed using 110 patients who had undergone radical nephrectomy for ccRCC. A 15-fold lasso and elastic-net regularized linear Cox model was used to develop the predictive gene expression signature. ...
Advertisement
Advertisement

Video Insights

Conferene Coverage

Knowledge Hub Spotlight

Renal Cell Carcinoma
Renal Cell Carcinoma
Advertisement
Section Editor

Advertisement
Get the latest RCC research straight to your inbox.